4D Molecular Therapeutics, Inc. Common Stock FDMT
$15.04
-4.96%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $31.33
- Implied Upside
- +108.3%
- Price Target Range
- $21.00 – $37.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-31 | B. Riley SecuritiesMayank Mamtani |
Initiates coverage on | Buy | $37 |
| 2026-07-20 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2026-03-30 | JefferiesFaisal Khurshid |
Assumes | Buy | $40 → $21 |
| 2026-03-20 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2026-03-19 | RBC CapitalLisa Walter |
Maintains | Outperform | $32 → $35 |
| 2026-03-19 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $26 |
| 2026-01-28 | BarclaysEliana Merle |
Initiates coverage on | Overweight | $33 |
| 2025-12-18 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $26 |
| 2025-11-11 | RBC CapitalLisa Walter |
Maintains | Outperform | $26 → $32 |
| 2025-11-11 | BarclaysGena Wang |
Maintains | Overweight | $38 → $33 |
| 2025-11-11 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $25 → $26 |
| 2025-10-21 | RBC CapitalLisa Walter |
Reiterates | Outperform | $26 |
| 2025-08-12 | Roth CapitalSalveen Richter |
Maintains | Buy | $44 → $38 |
| 2025-08-12 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $25 |
| 2025-08-01 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $25 |
| 2025-07-03 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $25 |
| 2025-05-09 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $28 → $25 |
| 2025-05-09 | Goldman SachsSalveen Richter |
Maintains | Buy | $51 → $44 |
| 2025-05-09 | BarclaysGena Wang |
Maintains | Overweight | $45 → $38 |
| 2025-03-10 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $42 → $40 |
| 2025-03-04 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $30 → $28 |
| 2025-03-03 | RBC CapitalLuca Issi |
Maintains | Outperform | $39 → $35 |
| 2025-03-03 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2025-02-11 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $39 → $30 |
| 2025-02-10 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2025-01-13 | Morgan StanleyJudah Frommer |
Maintains | Underweight | $8 → $6 |
| 2025-01-13 | Leerink PartnersMani Foroohar |
Maintains | Outperform | $31 → $27 |
| 2025-01-13 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $36 |
| 2024-12-18 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $79 → $46 |
| 2024-11-21 | Morgan StanleyJudah Frommer |
Initiates coverage on | Underweight | $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $15.04
- Market Cap
- $874.52 million
- 52-Week Range
- $4.14 – $16.93
- Average Volume
- 866K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.